ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Trimethyl Phosphate → 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2',3'-dideoxyuridine-5'-monophosphate

HRID 1672263
印刷

反応式

HRID 1672263 の反応式
[F:1][C:2]([F:29])([F:28])[C:3]([NH:5][CH2:6][CH2:7][O:8][CH2:9][C:10]#[C:11][CH2:12][C:13]1[C:14](=[O:27])[NH:15][C:16](=[O:26])[N:17]([CH:25]=1)[C@@H:18]1[O:24][C@H:21]([CH2:22][OH:23])[CH2:20][CH2:19]1)=[O:4].O=P(Cl)(Cl)Cl.[P:35](OC)([O:39]C)([O:37]C)=[O:36]>>[P:35]([O:23][CH2:22][C@H:21]1[O:24][C@@H:18]([N:17]2[CH:25]=[C:13]([CH2:12][C:11]#[C:10][CH2:9][O:8][CH2:7][CH2:6][NH:5][C:3](=[O:4])[C:2]([F:28])([F:1])[F:29])[C:14](=[O:27])[NH:15][C:16]2=[O:26])[CH2:19][CH2:20]1)([OH:39])([OH:37])=[O:36]
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 3

HCID 10541Trimethyl PhosphateHCID 24813Phosphorus oxychlorideHCID 600251125-(4-(n-Trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2',3'dideoxyuridine

生成物 1

HCID 600251115-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2',3'-dideoxyuridine-5'-monophosphate

実験手順

To a solution of 5 (30 mg, 0.0738 mmol) in P(O)(OCH3)3 (0.5 mL) was treated with POCl3 (70 μL, 0.73 mmol) at 0° C., followed by stirring at r.t for 2-3 h and then evaporating solvent under reduced pressure and purification by preparative reverse phase HPLC to afford the corresponding mono phosphate 6. 31P NMR (CD3OD, 121.4 MHz) δ 0.79 (s); 19F NMR (CDCl3, 282.2 MHz) δ −77.37 (s, CF3). To a dried solution of 6 in DMF (1 mL) were added 1,1′-carbonyldiimidazole (CDI, 33 mg, 0.21 mmol), followed by stirring at r.t. for 5 h and then quenching with MeOH (8 μL, 0.21 mmol). A solution of tetrabutylammonium pyrophosphate (TBAPP, 143.0 mg, 0.33 mmol) and tributyl amine (0.15 mL, 0.66 mmol) in DMF (1.5 mL) was added to the above solution at r.t under Ar, followed by stirring overnight and then quenched with 2.0 M TEAB. After evaporating solvent, the organic residue was purified by preparative reverse phase HPLC with 100 mM TEAA/AcCN (0 to 50% gradient) to give the corresponding triphosphate 7. 1H NMR (D2O, 300 MHz) δ 7.74 (s, 1H, H6), 5.95 (dd, 1H, H1′, J=3.3 and 6.3 Hz), 4.29-4.20 (m, 1H, H4′), 4.18-4.07 (m, 3H, CH2 and H5′), 4.02-3.92 (m, 1H, H5′), 3.58 (t, 2H, CH2, J=5.1 Hz), 3.38 (t, 2H, CH2, J=5.1 Hz), 3.20 (s, 2H, CH2), 2.35-2.22 (m, 1H, H2′), 2.10-1.92 (m, 3H, H2′ and 2H3′). 31P NMR (D2O, 121.4 MHz) δ −10.52 (d, J=19.2 Hz), −10.95 (d, J=20.3 Hz), −22.96 (t, J=20.3 Hz); 19F NMR (D2O, 282.2 MHz) δ −76.37 (s, CF3). Removal of trifluro acetate (TFA) protecting group was accomplished by treatment with NH4OH (33%, 500 μL) at 60° C. for 20 min and then at r.t for 1 h to give the corresponding triphosphate 8 (17 mM, 500 μL).

後処理

  1. customevaporating solvent under reduced pressure and purification by preparative reverse phase HPLC

出典と根拠

ORDレコード
ord-fe44e7216e954974af04587bd5be9015
出典データセット
uspto-grants-2011_08
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07998706B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート